Impact of Timing of Tocilizumab Use in Hospitalized Patients With SARS-CoV-2 Infection

Abstract

Early use of anti-interleukin 6 therapy may be associated with improved hospital mortality and reduction in progression to more severe coronavirus disease 2019.